Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 1/2 1

Status

Completed 329Terminated 77Recruiting 45Unknown 30Active not recruiting 29Withdrawn 18Not yet recruiting 5Suspended 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Sarcoma 1Breast 1

Conditions

Leukemia, Myeloid, Acute 2Sarcoma 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 126Cisplatin 125Drug Therapy 103Bevacizumab 98Oxaliplatin 97Capecitabine 97Radiotherapy 94Gemcitabine 87Paclitaxel 85tislelizumab 84Cyclophosphamide 82pembrolizumab 77Specimen Handling 77toripalimab 69Injections 63Fluorouracil 62Magnetic Resonance Spectroscopy 61sintilimab 57anlotinib 53130-nm albumin-bound paclitaxel 51Surgical Procedures, Operative 50Docetaxel 49fludarabine 46Pemetrexed 45venetoclax 42Standard of Care 42Leucovorin 42Irinotecan 41lenvatinib 40Biopsy 39

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Granulocyte Colony-Stimulating Factor × Clear all
NCT07602777 2026-05-22

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

GlaxoSmithKline

Phase 1/2 Not yet recruiting
113 enrolled
Sarcoma

Sarcoma

NCT07507825 2026-04-02

VHAG

First People's Hospital of Hangzhou

Phase 2 Not yet recruiting
61 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07441967 2026-03-02

The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Not yet recruiting
44 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT07367178 2026-01-28

SATROPIN

MedSIR

Phase 2 Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

NCT06763666 2025-01-08

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Nanfang Hospital, Southern Medical University

Phase 4 Not yet recruiting
172 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡